- Home
- BNZI vs ADXN Comparison
BNZI vs ADXN Comparison
Compare BNZI & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- ADXN
- Stock Information
- Founded
- BNZI 2016
- ADXN 2002
- Country
- BNZI United States
- ADXN Switzerland
- Employees
- BNZI N/A
- ADXN N/A
- Industry
- BNZI
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- BNZI
- ADXN Health Care
- Exchange
- BNZI Nasdaq
- ADXN Nasdaq
- Market Cap
- BNZI 16.5M
- ADXN 8.1M
- IPO Year
- BNZI N/A
- ADXN N/A
- Fundamental
- Price
- BNZI $0.64
- ADXN $9.13
- Analyst Decision
- BNZI Strong Buy
- ADXN Strong Buy
- Analyst Count
- BNZI 1
- ADXN 1
- Target Price
- BNZI $24.00
- ADXN $30.00
- AVG Volume (30 Days)
- BNZI 4.1M
- ADXN 16.0K
- Earning Date
- BNZI 08-13-2025
- ADXN 06-19-2025
- Dividend Yield
- BNZI N/A
- ADXN N/A
- EPS Growth
- BNZI N/A
- ADXN N/A
- EPS
- BNZI N/A
- ADXN 0.10
- Revenue
- BNZI $6,827,490.00
- ADXN $278,508.00
- Revenue This Year
- BNZI $570.18
- ADXN $86.57
- Revenue Next Year
- BNZI $34.44
- ADXN N/A
- P/E Ratio
- BNZI N/A
- ADXN $0.78
- Revenue Growth
- BNZI 52.95
- ADXN N/A
- 52 Week Low
- BNZI $0.54
- ADXN $6.51
- 52 Week High
- BNZI $11.20
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- BNZI 38.68
- ADXN 55.63
- Support Level
- BNZI $0.54
- ADXN $8.50
- Resistance Level
- BNZI $0.74
- ADXN $9.87
- Average True Range (ATR)
- BNZI 0.10
- ADXN 0.78
- MACD
- BNZI 0.00
- ADXN 0.04
- Stochastic Oscillator
- BNZI 20.94
- ADXN 60.00
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.